Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.
3.

Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.

da Silva PM.

Clin Drug Investig. 2010;30(9):625-41. doi: 10.2165/11538440-000000000-00000. Review.

PMID:
20626210
5.

Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.

Frampton JE, Scott LJ.

Am J Cardiovasc Drugs. 2009;9(5):309-30. doi: 10.2165/11201120-000000000-00000. Review.

PMID:
19791840
6.
8.

Azilsartan, aliskiren, and combination antihypertensives utilizing renin-angiotensin-aldosterone system antagonists.

Lanier G, Sankholkar K, Aronow WS.

Am J Ther. 2014 Sep-Oct;21(5):419-35. doi: 10.1097/MJT.0b013e31824a0ed7. Review.

PMID:
22975662
9.

Amlodipine and valsartan as components of a rational and effective fixed-dose combination.

Waeber B, Ruilope LM.

Vasc Health Risk Manag. 2009;5(1):165-74. Epub 2009 Apr 8. Review.

10.

Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.

Ferri C, Croce G, Desideri G.

Adv Ther. 2008 Apr;25(4):300-20. doi: 10.1007/s12325-008-0042-x. Review.

PMID:
18449492
11.
12.

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.

Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.

Clin Ther. 2007 Feb;29(2):279-89.

PMID:
17472820
13.

Pharmacokinetics, tolerability, and safety of the single oral administration of AGSAV301 vs Exforge: a randomized crossover study of healthy male volunteers.

Choi HY, Kim YH, Kim MJ, Noh YH, Lee SH, Bae KS, Lim HS.

Am J Cardiovasc Drugs. 2014 Feb;14(1):63-72. doi: 10.1007/s40256-013-0051-2.

PMID:
24174172
14.

Valsartan/amlodipine single pill combination for the treatment of hypertension.

Düsing R.

Expert Rev Clin Pharmacol. 2010 Nov;3(6):739-46. doi: 10.1586/ecp.10.57.

PMID:
22111777
15.

Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker.

Bakris GL.

J Clin Hypertens (Greenwich). 2008 Jan;10(1 Suppl 1):27-32. Review.

16.
19.

Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utility.

Nash DT, McNamara MS.

Integr Blood Press Control. 2009;2:39-54. Epub 2009 Oct 28.

Supplemental Content

Support Center